Profiling of Somatic Mutations in Phaeochromocytoma and Paraganglioma by Targeted Next Generation Sequencing Analysis
Andrea Luchetti(University of Cambridge), Eamonn R. Maher(Aston University), Howard Martin(Cambridge University Hospitals NHS Foundation Trust), Richard Irving(Selly Oak Hospital), Masahiro Yao(Yokohama City University), Mercedes Robledo(The University of Texas at San Antonio Health Science Center), Graeme M. Clark(Cancer Research UK), Farida Latif(University of Birmingham), Diana Walsh(University of Birmingham), Stephen Abbs(Guy's Hospital), T. Martin(Queen Elizabeth Hospital Birmingham), Mario Sanna(North American Skull Base Society), Fay Rodger(Addenbrooke's Hospital), Hartmut P.H. Neumann(University of Freiburg), Emma R. Woodward(Royal Manchester Children's Hospital)
Cited by 91
Related Papers
Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma
|The American Journal of Human Genetics|2001|1.1k
Clinical and molecular diagnosis, screening and management of Beckwith–Wiedemann syndrome: an international consensus statement
|Nature Reviews Endocrinology|2018|596
An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis
|The Lancet Oncology|2009|536
Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma
|Nature Genetics|2011|528